Company Filing History:

10 out of 449

Alcon Laboratories, Inc.

Alcon Manufacturing, Ltd.

Years Active: 1995-2011

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8084054 - Bioerodible film for ophthalmic drug delivery (2011-12-27),

2. 6646003 - Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac (2003-11-11),

3. 6645978 - Lipoxin A4 and its analogs for the treatment of dry eye (2003-11-11),

4. 6638976 - Method of treating neurodegenerative disorders of the retina and optic nerve head (2003-10-28),

5. 6458854 - Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use (2002-10-01),

6. 6458853 - Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use (2002-10-01),

7. 6437160 - 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use (2002-08-20),

8. 6433007 - Methods for the prevention and treatment of post-surgical complications (2002-08-13),

9. 6420399 - Topical ophthalmic mast cell stabilizers for treating allergic eye disease (2002-07-16),

10. 6399107 - Use of inhibitors of gag synthesis for the treatment of corneal haze (2002-06-04),

11. 6353032 - Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use (2002-03-05),

12. 6353012 - 15-Hydroxyeicosatetraenoic acid-related compounds and methods of use (2002-03-05),

13. 6331644 - 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use (2001-12-18),

14. 6242480 - Ophthalmic viscoelastic compositions (2001-06-05),

15. 6022699 - Myeloperoxidase assay of endotoxin-induced inflammation (2000-02-08),

Title: Unveiling the Innovations of Gustav Graff: Pioneering Ophthalmic Solutions.

Introduction:

Gustav Graff, a visionary inventor hailing from Cleburne, TX, has made remarkable strides in the field of ophthalmic drug delivery. With an impressive portfolio of 22 patents to his name, Gustav is at the forefront of developing cutting-edge solutions to enhance eye health and treatment efficacy.

Latest Patents:

Gustav Graff's recent patents include groundbreaking inventions such as the "Bioerodible Film for Ophthalmic Drug Delivery." This innovation showcases the use of water-soluble, film-forming polymers combined with fatty acid glycerides to efficiently deliver ophthalmic drugs. Additionally, his patent on "Lipoxin A4 and its Analogs for the Treatment of Dry Eye" highlights the development of ophthalmic compositions for addressing dry eye conditions using Lipoxin A and its analogs.

Career Highlights:

Having excelled in his career, Gustav Graff has lent his expertise to renowned companies such as Alcon Laboratories, Inc. and Alcon Universal Ltd. Through his relentless dedication and ingenuity, he has significantly contributed to advancing the field of ophthalmology and pharmaceuticals. His patents stand as a testament to his innovative spirit and commitment to improving patient outcomes.

Collaborations:

In his professional journey, Gustav Graff has collaborated with esteemed individuals like Mark R. Hellberg and John M. Yanni. Together, they have synergized their expertise to drive forward pioneering research and development initiatives in the realm of ophthalmic innovations.

Conclusion:

Gustav Graff's pioneering work in ophthalmic drug delivery underscores his unwavering commitment to revolutionizing patient care. His inventions not only exemplify his technical prowess but also reflect his profound impact on the healthcare industry. As Gustav continues to push the boundaries of innovation, the future holds boundless possibilities for transformative advancements in ophthalmic treatments and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com